Literature DB >> 16614246

The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function.

Mojca Skoberne1, Selin Somersan, Wanda Almodovar, Tuan Truong, Kseniya Petrova, Peter M Henson, Nina Bhardwaj.   

Abstract

Dendritic cells (DCs) that capture apoptotic cells (ACs) in the steady state mediate peripheral tolerance to self-antigens. ACs are recognized by an array of receptors on DCs, the redundancy of which is not completely defined. We made use of an AC surrogate system to address the individual roles of the alphavbeta5 and complement receptors (CRs) in the phagocytosis and induction of immunity. CR3 and CR4, while substantially less efficient than alphavbeta5 in internalizing ACs, initiate signals that render DCs tolerogenic. Responding T cells show impaired proliferation and IFNgamma production and subsequently die by apoptosis. While tolerogenic DCs are not induced via alphavbeta5, coligation of CR3 and alphavbeta5 maintains the DC's tolerogenic profile. This immunomodulatory role, however, is countered by a significant inflammatory stimulus such as bacterial infection. Overall, our data suggest that under steady-state conditions, signaling via CRs predominates to render DCs tolerogenic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614246      PMCID: PMC1895855          DOI: 10.1182/blood-2005-12-4812

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells.

Authors:  Jean Francois Fonteneau; Daniel G Kavanagh; Margareta Lirvall; Catherine Sanders; Timothy L Cover; Nina Bhardwaj; Marie Larsson
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

2.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

Authors:  J Savill; N Hogg; Y Ren; C Haslett
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases.

Authors:  Wai-Kee Ip; Yu-Lung Lau
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

4.  Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

Authors:  Nicholas S Wilson; Dima El-Sukkari; Gabrielle T Belz; Christopher M Smith; Raymond J Steptoe; William R Heath; Ken Shortman; José A Villadangos
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

5.  Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression.

Authors:  Stefanie Kirchberger; Otto Majdic; Peter Steinberger; Stefan Blüml; Katharina Pfistershammer; Gerhard Zlabinger; Luiza Deszcz; Ernst Kuechler; Walter Knapp; Johannes Stöckl
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

6.  Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.

Authors:  B L Myones; J G Dalzell; N Hogg; G D Ross
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

7.  Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.

Authors:  G D Ross; J A Cain; P J Lachmann
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

Review 8.  Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

9.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

Authors:  Ulrich E Schaible; Florian Winau; Peter A Sieling; Karsten Fischer; Helen L Collins; Kristine Hagens; Robert L Modlin; Volker Brinkmann; Stefan H E Kaufmann
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

Review 10.  Novel IL-12 family members shed light on the orchestration of Th1 responses.

Authors:  Frank Brombacher; Robert A Kastelein; Gottfried Alber
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

View more
  47 in total

Review 1.  Enhancement of dendritic cells as vaccines for cancer.

Authors:  Meghan E Turnis; Cliona M Rooney
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice.

Authors:  Chang-Qing Xia; Yushi Qiu; Rui-Hua Peng; Jeannette Lo-Dauer; Michael J Clare-Salzler
Journal:  J Autoimmun       Date:  2008-01-15       Impact factor: 7.094

3.  Activation outcomes induced in naïve CD8 T-cells by macrophages primed via "phagocytic" and nonphagocytic pathways.

Authors:  Isabel María Olazabal; Noa Beatriz Martín-Cofreces; María Mittelbrunn; Gloria Martínez del Hoyo; Balbino Alarcón; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2007-12-12       Impact factor: 4.138

Review 4.  Directing dendritic cell immunotherapy towards successful cancer treatment.

Authors:  Rachel Lubong Sabado; Nina Bhardwaj
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

5.  IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity.

Authors:  Karla D Kenyon; Caroline Cole; Fran Crawford; John W Kappler; Joshua M Thurman; Donna L Bratton; Susan A Boackle; Peter M Henson
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

6.  Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.

Authors:  T Nikolic; N J C Woittiez; A van der Slik; S Laban; A Joosten; C Gysemans; C Mathieu; J J Zwaginga; B Koeleman; B O Roep
Journal:  Genes Immun       Date:  2017-08-10       Impact factor: 2.676

7.  Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3.

Authors:  Rada Ellegård; Elisa Crisci; Adam Burgener; Christopher Sjöwall; Kenzie Birse; Garrett Westmacott; Jorma Hinkula; Jeffrey D Lifson; Marie Larsson
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

8.  Complement receptor 3 influences toll-like receptor 7/8-dependent inflammation: implications for autoimmune diseases characterized by antibody reactivity to ribonucleoproteins.

Authors:  Joanne H Reed; Manish Jain; Kristen Lee; Ekambar R Kandimalla; Mohd Hafeez Faridi; Jill P Buyon; Vineet Gupta; Robert M Clancy
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

9.  Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Authors:  Zoltán Bánki; Wilfried Posch; Asim Ejaz; Verena Oberhauser; Suzanne Willey; Christoph Gassner; Heribert Stoiber; Ulf Dittmer; Manfred P Dierich; Kim J Hasenkrug; Doris Wilflingseder
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

Review 10.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.